Development in wastewater treatment research and processes : innovative trends in removal of refractory pollutants from pharmaceutical wastewater /

Development in Wastewater Treatment Research and Processes: Innovative Trends in Removal of Refractory Pollutants from Pharmaceutical Waste Water sorts out emerging and burning issues faced by the pharmaceutical industry, along with common effluent treatment plans.

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Rodriguez-Couto, Susana, Shah, Maulin P.
Format: eBook
Language:English
Published: Amsterdam : Elsevier, 2024.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Front Cover
  • Development in Wastewater Treatment Research and Processes
  • Development in Wastewater Treatment Research and Processes
  • Contents
  • Contributors
  • 1
  • Pharmaceutical wastewater management: Physicochemical, chemical, and biological approaches
  • 1. Introduction
  • 2. Pharmaceutical compounds present in the wastewater
  • 3. Physicochemical approach for the elimination of emerging contaminants
  • 3.1 Coagulative precipitation
  • 3.2 Electrocoagulation
  • 3.3 Sedimentation
  • 3.4 Floatation
  • 3.5 Electrolysis
  • 3.6 Adsorption
  • 3.7 Membrane separation
  • 4. Chemical approach for removing emerging contaminants
  • 4.1 Advanced oxidation
  • 4.2 Wet air oxidation (WAO)
  • 4.3 Supercritical water oxidation (SCWO)
  • 4.4 Electro-fenton reagent
  • 4.5 Biological electro fenton (Bio-EF)
  • 4.6 Photocatalytic oxidation
  • 4.7 Ultrasound oxidation (UAO)
  • 4.8 Electrochemical oxidation
  • 4.9 Ozonation
  • 4.10 Perozonation
  • 4.11 Iron-carbon method
  • 4.12 Chlorination
  • 4.13 Flocculation
  • 5. Biological treatment approach for the removal of emerging contaminants
  • 5.1 Activated sludge process (ASP)
  • 5.2 Sequence batch reactor (SBR)
  • 5.3 Moving bed biofilm reactor (MBBR)
  • 5.4 Membrane bioreactor (MBR)
  • 5.5 Trickling filter (TF)
  • 5.6 Anaerobic treatment system
  • 5.6.1 Hybrid anaerobic+biological system
  • 5.6.2 Hybrid anaerobic+chemical/physical systems
  • 5.7 Hybrid biological-physical- treatment processes
  • 5.8 Hybrid biological-physical-chemical treatment processes
  • 6. Phyto-remediation approaches for pharmaceuticals wastewater treatment
  • 7. Mycoremediation approaches for pharmaceuticals wastewater treatment
  • 8. Phyco-remediation approaches for pharmaceutical wastewater treatment
  • 9. Pharmaceuticals wastewater treatment during the COVID-19 pandemic.
  • 10. Clustered regularly interspaced palindromic repeats (CRISPR) assisted bioremediation approach
  • 11. Conclusion
  • References
  • 2
  • Applications of ultrafiltration, nanofiltration, and reverse osmosis in pharmaceutical wastewater treatment
  • 1. Introduction
  • 2. Membrane separation approaches
  • 3. Removal of emerging pharmaceutical contaminants by nanofiltration membrane system
  • 4. Removal of the emerging pharmaceutical contaminants by ultrafiltration membrane system
  • 5. Removal of emerging contaminants by reverse osmosis membrane system
  • 6. Conclusion
  • References
  • 3
  • Recent advancement in bioremediation of pharmaceutical wastewater
  • 1. Introduction
  • 2. Refractory pollutants
  • 3. Pharmaceutical industry wastewater (PIWW)
  • 4. Bioremediation
  • 4.1 Bioadsorption
  • 4.2 Bioaccumulation
  • 4.3 Biodegradation
  • 4.4 Photo-biodegradation
  • 4.5 Volatilization
  • 5. Microorganisms involved in bioremediation of PIWW
  • 5.1 Bacterial bioremediation
  • 5.2 Fungal bioremediation
  • 5.3 Phycoremediation
  • 5.4 Phytoremediation
  • 6. Membrane bioreactors
  • 7. Enzyme-driven bioremediation
  • 8. Future perspective of bioremediation in PIWW treatment
  • 9. Conclusions
  • References
  • 4
  • Hybrid membrane processes equipped with crystallization unit for a simultaneous recovery of freshwater and mine ...
  • 1. Introduction
  • 2. Principles of membrane crystallization
  • 2.1 Module configurations in membrane distillation crystallization
  • 2.1.1 DCMD
  • 2.1.2 AGMD
  • 2.1.3 VMD
  • 2.1.4 SGMD
  • 2.2 Process of crystallization and precipitation
  • 2.3 Factors affecting crystallization
  • 2.3.1 Temperature
  • 2.3.2 Flowrate
  • 2.3.3 Concentration of the feed solution
  • 3. Membranes used in membrane crystallization
  • 4. Fouling and wetting in membrane crystallization
  • 5. Fouling and wetting mitigation strategies
  • 5.1 Membrane modification.
  • 5.2 Membrane cleaning
  • 5.3 Pre-treatment processes
  • 6. Application of membrane crystallization for the treatment of wastewater
  • 7. Conclusion
  • References
  • 5
  • Advanced (nano)materials
  • 1. Introduction
  • 2. Green nanotechnology
  • 3. Green nanomaterial preparation
  • 3.1 Physical method
  • 4. Chemical method
  • 5. Biological method
  • 6. Biosynthesis of NPs using microorganisms
  • 6.1 Synthesis of nanoparticles using fungi
  • 7. Synthesis of nanoparticles using yeast
  • 8. Synthesis of nanoparticles using bacteria
  • 9. Synthesis of nanoparticles using actinomycetes
  • 10. Synthesis of nanoparticles using plant
  • 11. Applications of green nanomaterials
  • 12. Environmental cleanup
  • 13. Nanoremediation
  • 14. Nanomaterials as adsorbents for water treatment
  • 15. Nanomaterials in photocatalysis
  • 16. Copper oxide in photocatalysis
  • 17. Nanosized iron oxides
  • 18. Magnesium oxide NPs (MgO-NPs)
  • 19. Nanocomposites in water treatment
  • 20. Nanocomposite membrane
  • 21. Magnetic nanocomposites
  • 22. Chitosan NPs
  • 23. Cellulose based nanoadsorbent
  • 24. Dendrimer nanoadsorbent
  • 25. Major problems in photocatalysis processes
  • 26. Reusability of nanocomposites
  • 27. Disinfection
  • 28. Conclusion
  • References
  • 6
  • Removal of pharmaceutical contaminants from wastewater using activated sludge process
  • 1. Introduction
  • 1.1 Pharmaceutical manufacturing industries
  • 1.2 Human and animal excretions
  • 1.3 Hospital and clinic effluents
  • 2. Major units of activated sludge process based wastewater treatment
  • 2.1 Screening
  • 2.2 Grit chamber
  • 2.3 Primary settling tank
  • 2.4 Aeration tank
  • 2.5 Secondary clarifier
  • 3. Removal of pharmaceutical contaminants by activated sludge process
  • 3.1 Hydraulic retention time (HRT)
  • 3.2 Sludge retention time (SRT)
  • 3.3 Redox conditions and temperature.
  • 4. Removal process in ASP for pharmaceuticals
  • 4.1 Biodegradation
  • 4.2 Sorption
  • 5. Techniques to enhance elimination of pharmaceutical in ASP
  • 5.1 Activated carbon insertion
  • 5.2 Hybridization with ASP
  • 6. Conclusion
  • References
  • 7
  • Bacteria mediated cadmium removal for wastewater treatment
  • 1. Introduction
  • 2. Cadmium toxicity
  • 3. Conventional methods of cadmium removal
  • 4. Bacteria mediated cadmium removal
  • 5. Conclusions and future perspectives
  • References
  • 8
  • Oxidation and advanced oxidation processes in pharmaceutical wastewater treatment
  • 1. Introduction
  • 2. Organic contaminants in waste water
  • 3. Oxidation processes
  • 4. Advance oxidation processes
  • 5. Principle and types of AOP
  • 6. Mechanism of AOPs
  • 7. Advanced AOPs catalyzed by hydrogen peroxide
  • 8. AOPs using UV radiation
  • 9. Strategies for efficient optimization of AOPs
  • 10. Merits of AOPs
  • 11. Limitations of AOPs
  • 12. Studies on AOPs for waste water treatment
  • 13. Conclusion and future trend
  • References
  • 9
  • Nanomaterials for the removal of pollutants from pharmaceutical wastewater
  • 1. Introduction
  • 2. Physio-chemical properties of pharmaceutical pollutants
  • 3. Toxicological impact of pharmaceutical pollutants on ecosystem
  • 4. Synthesis techniques of nanostructure materials
  • 4.1 Chemical vapor deposition
  • 4.2 Ball milling
  • 4.3 Pyrolysis
  • 4.4 Hydrothermal carbonization
  • 4.5 Exfoliation
  • 5. Mechanism behind the removal of contaminates by nanomaterials
  • 6. Application of nanomaterials for the removal of pharmaceuticals
  • 6.1 Carbon based nanomaterials
  • 6.1.1 Carbon nanotubes
  • 6.1.2 GO based nanomaterials
  • 6.1.3 RGO based nanomaterials
  • 6.2 Metal-based nanomaterials
  • 7. Limitations
  • 8. Conclusion and prospects
  • References.
  • 10
  • Bio nanotechnology: An emerging tools to remove refractory pollutant from pharmaceutical wastewater
  • 1. Introduction
  • 2. Methods for treatment of pharmaceutical waste water
  • 3. Nanotechnology
  • 4. Synthesis of nanoparticles
  • 4.1 Nanoparticles produced by plants
  • 5. Bacteria-generated nanoparticles
  • 6. Yeast and fungal nanoparticles
  • 7. Nanotechnology for bioremediation
  • 8. Different nanomaterials and treatment of pharmaceutical waste water
  • 9. Nanofilter membrane bioreactor
  • 10. Nanoadsorbants
  • 11. Nanocatalyst
  • 12. Conclusion
  • References
  • 11
  • Bioremediation of pharmaceutical contaminants from wastewater by mushrooms
  • 1. Introduction
  • 2. Pharmaceutical residues
  • 3. Wastewater treatment
  • 4. Mushrooms in bioremediation of pharmaceutical contaminants from wastewater
  • 4.1 Pleurotus sp.
  • 4.2 Trametes versicolor
  • 4.3 Phanerochaete chrysosporium
  • 4.4 Agaricus bisporus and Lentinula edodes
  • 5. Perspectives and conclusions
  • References
  • 12
  • Microbial bioremediation potentials for refractory pollutants removal from pharmaceutical wastewater
  • 1. Introduction
  • 2. Nature and origin of pharmaceutical wastes
  • 3. Bioremediation in treatment of pharmaceutical wastes
  • 3.1 Bacteria and actinomycetes in bioremediation
  • 3.2 Ultrafiltration membrane biological reactor based on nitrifying bacteria
  • 3.3 Fungal bioremediation
  • 3.4 Microalgal bioremediation (phycoremediation)
  • 3.5 Technologies used to improve microbial bioremediation
  • 4. Future prospects and conclusion
  • References
  • 13
  • Innovative technologies for emerging issues in pharmaceuticals
  • 1. Introduction
  • 2. State of the art on the occurrence of pharmaceuticals all over the world
  • 3. New emerging technologies for the removal of pharmaceuticals from the environment.